Loading...

PONTOCEREBELLAR HYPOPLASIA GENE PANEL BY NGS, EDTA BLOOD

image not found

NABL Cap Accredited 

The Pontocerebellar Hypoplasia Gene Panel by NGS is a specialized genetic test designed to detect mutations associated with various subtypes of pontocerebellar hypoplasia, a group of rare neurodevelopmental disorders. Metropolis Healthcare uses advanced Next-Generation Sequencing (NGS) to analyze multiple genes involved in brain development and neuronal function. This test supports early and accurate diagnosis in individuals with severe developmental delays, movement disorders, or structural brain abnormalities. It also aids clinicians and families by providing clarity on prognosis and inheritance risks. 

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 21,000.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes:G0241

Frequently Asked Questions (FAQ's):

What does the Pontocerebellar Hypoplasia Gene Panel include?
It includes comprehensive sequencing by Metropolis Healthcare to identify mutations linked to different forms of pontocerebellar hypoplasia.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses high-precision NGS to analyze multiple neurodevelopmental genes from an EDTA blood sample.

Who should take this test?
Infants or children with severe developmental delays, microcephaly, feeding difficulties, or MRI findings suggestive of PCH may benefit.

Can this test confirm the subtype of pontocerebellar hypoplasia?
Yes, identifying specific gene mutations helps classify the PCH subtype and guide prognosis.

What sample is required for this test?
An EDTA blood sample is used for detailed DNA extraction and gene sequencing.

Is this test useful for family counseling?
Yes, it supports understanding of inheritance patterns and recurrence risks for future pregnancies.

How long does Metropolis Healthcare take to provide results?
Results typically take a few weeks due to extensive sequencing and expert interpretation.

Does this test help in management or treatment planning?

While treatment is supportive, genetic confirmation helps clinicians tailor care, anticipate complications, and plan long-term monitoring 

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab